Avantor® Participates In Bioprocess International 2024 Conference Scientific Program And Exhibition

(MENAFN- PR Newswire) RADNOR, Pa., Sept. 23, 2024 /PRNewswire/ -- Avantor, Inc. (NYSE: AVTR ), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, announced the Company will deliver multiple scientific presentations and exhibit at BioProcess International 2024, scheduled for September 23-26 in Boston. Over 3,200 biopharmaceutical development and production professionals representing 40-plus countries are expected to attend.

Avantor's scientific presentations at BioProcess International 2024 include:

Presenter - Jungmin Oh, Ph.D., Senior Manager, New Product Development
Session Title - A novel approach to optimization of AAV harvest and purification process
Date and Time - September 25, 12:30 pm

Presenter - Nandu Deorkar, Ph.D., Senior Vice President, Biopharma Production Research & Development
Session Title - Keynote Address: Adapting to Changing Molecules and Regulatory Expectations
Date and Time – September 26, 10:00 am

Presenter - Jerry Keybl, Ph.D., Senior Vice President, Biopharma Products & Strategy
Session Title - Viral Gene Therapy Manufacturing at Scale – Assembling Solutions to Drive Industrialization
Date and Time - September 26, 12:15 pm

"Avantor's significant presence at BioProcess International 2024 is a testament to our reputation for delivering leading solutions across the spectrum of biopharmaceutical development and production," said Benoit Gourdier, Executive Vice President and Head of Avantor's Bioscience Production Segment. "We look forward to engaging with customers and attendees in Boston and showcasing how our innovative solutions can help solve their most demanding production challenges."

In addition to its multiple scientific presentations, Avantor will also have a strong presence on the exhibit floor, focusing on its industry leading solutions for production scale up and downstream process optimization. Avantor will present its Magnetic Mixing Systems portfolio, which ranges from 50 to 1500 liters, and now includes a newly launched tabletop mixer for single-use mixing needs. These scalable Magnetic Mixing Systems are designed to maximize mixing efficiency with low shear rates, ensuring consistent homogeneity and minimizing risk to product quality. Avantor's experienced team of engineers can also help design specialized solutions tailored to customers unique bioprocessing mixing needs.

About Avantor
Avantor® is a leading life science tools company and global provider of mission-critical products and services to the life sciences and advanced technology industries. We work side-by-side with customers at every step of the scientific journey to enable breakthroughs in medicine, healthcare, and technology. Our portfolio is used in virtually every stage of the most important research, development and production activities at more than 300,000 customer locations in 180 countries. For more information, visit
avantorsciences
and find us on
LinkedIn ,
X (Twitter)
and
Facebook .

Global Media Contact
Eric Van Zanten
Head of External Communications
Avantor
610-529-6219
[email protected]

Investor Relations Contact
Christina Jones
Vice President, Investor Relations
Avantor
805-617-5297
[email protected]

SOURCE Avantor and Financial News

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE? 440k+
Newsrooms &
Influencers 9k+
Digital Media
Outlets 270k+
Journalists
Opted In GET STARTED

MENAFN23092024003732001241ID1108704052